Unknown

Dataset Information

0

Preparing for the Next Normal: Transformation in the Role of Medical Affairs Following the COVID-19 Pandemic.


ABSTRACT: The medical affairs function represents one of the scientific interfaces in a pharmaceutical organization. Over the last two decades, medical affairs has evolved from being a support function to a strategic pillar within organizational business units. The COVID-19 pandemic has given rise to unforeseen circumstances resulting in a dramatic change in external stakeholder engagements, catapulting the medical affairs function into leading the way on scientific engagements and patient-centric endeavors. The changes in stakeholder interactions and behavior as a result of the pandemic last year are likely to persist in the foreseeable future for which medical affairs professionals need to enhance existing skill sets and acquire expertise in newer domains. In this paper, the transformation of the medical affairs team to a key strategic partner and the skills required to strengthen this transition, in the next normal of a post-COVID world, is explored.

SUBMITTER: Ghosh R 

PROVIDER: S-EPMC8256774 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7312045 | biostudies-literature
| S-EPMC8603440 | biostudies-literature
| S-EPMC7836946 | biostudies-literature
| S-EPMC8132916 | biostudies-literature
| S-EPMC9232529 | biostudies-literature
| S-EPMC9282759 | biostudies-literature
| S-EPMC9509531 | biostudies-literature
| S-EPMC8425853 | biostudies-literature
| S-EPMC9000913 | biostudies-literature
| S-EPMC10382121 | biostudies-literature